- Lexicon Pharmaceuticals (NASDAQ:LXRX) Q4 results: Revenues: $23M (-81.9%); Operating Loss: ($31.3M) (-135.4%); Net Loss: ($32.4M) (-137.3%); Loss Per Share: ($0.31) (-140.8%).
- 2016 results: Revenues: $83.3M (-35.9%); Operating Loss: ($137.2M); Net Loss: ($141.4M); Loss Per Share: ($1.36); Quick Assets: $346.5M (-33.5%).
- No guidance given.
- Shares are up 4.4% premarket.
Lexicon Pharma revenues off 36% in FY16; shares up 4% premarket
Recommended For You
About LXRX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| LXRX | - | - |
| Lexicon Pharmaceuticals, Inc. | ||